Trade

with

Omnicare Inc
(NYSE: OCR)
AdChoices
66.45
+2.37
+3.70%
After Hours :
65.00
-1.45
-2.18%

Open

65.00

Previous Close

64.08

Volume (Avg)

2.43M (844.42k)

Day's Range

64.31-67.66

52Wk Range

53.38-67.66

Market Cap.

6.27B

Dividend Rate (Yield )

0.80 (1.25%)

Beta

1.28

Shares Outstanding

97.85M

P/E Ratio (EPS)

60.98 (-)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Care
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 6.01B

    • Net Income

    • -43.43M

    • Market Cap.

    • 6.27B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1.03

    • PEG (Price/Earnings Growth) Ratio

    • 1.59

    • Beta

    • 1.28

    • Forward P/E

    • 15.46

    • Price/Sales

    • 1.12

    • Price/Book Value

    • 2.41

    • Price/Cash flow

    • 11.57

      • EBITDA

      • 430.81M

      • Return on Capital %

      • -0.96

      • Return on Equity %

      • -2.11

      • Return on Assets %

      • -0.96

      • Book Value/Share

      • 26.57

      • Shares Outstanding

      • 97.85M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.20 (9/18/2014)

      • Dividend Declaration Date

      • 9/12/2014

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 68.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 3.38

        • Cashflow Estimate

        • 5.37

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 7.10

          • 10.91

          • Net Income

            YTD/YTD (last year)

          • -56.40

          • 13.51

          • Net Income

            Q/Q (last year)

          • 29.50

          • 9.25

          • Sales (Revenue)

            5-Year Annual Average

          • -0.96

          • 22.28

          • Net Income

            5-Year Annual Average

          • -11.50

          • 7.43

          • Dividends

            5-Year Annual Average

          • 47.11

          • 7.69

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 22.85

            • 20.03

            • Pre-Tax Margin

            • 3.56

            • 6.27

            • Net Profit Margin

            • -1.03

            • 3.77

            • Average Gross Margin

              5-Year Annual Average

            • 23.30

            • 20.79

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 3.30

            • 6.01

            • Average Net Profit Margin

              5-Year Annual Average

            • 1.10

            • 210.16B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.66

              • 0.69

              • Current Ratio

              • 1.70

              • 1.48

              • Quick Ratio

              • 0.92

              • 0.75

              • Interest Coverage

              • -

              • 11.79

              • Leverage Ratio

              • 2.50

              • 2.42

              • Book Value/Share

              • 26.57

              • 17.00

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 60.98

                • 24.69

                • P/E Ratio 5-Year High

                • 64.16

                • 101.38

                • P/E Ratio 5-Year Low

                • 18.20

                • 15.89

                • Price/Sales Ratio

                • 1.12

                • 0.86

                • Price/Book Value

                • 2.41

                • 3.36

                • Price/Cash Flow Ratio

                • 11.57

                • 11.49

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -2.11

                    (1.90)

                  • 12.59

                    (10.63)

                  • Return on Assets %

                    (5-Year Average)

                  • -0.96

                    (0.90)

                  • 6.43

                    (5.79)

                  • Return on Capital %

                    (5-Year Average)

                  • -1.24

                    (2.40)

                  • 8.91

                    (7.75)

                  • Income/Employee

                  • -

                  • 8.31k

                  • Inventory Turnover

                  • 11.87

                  • 9.85

                  • Asset Turnover

                  • 0.93

                  • 1.70

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  297.85M
                  Operating Margin
                  4.95
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  11.57
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  47.30%

                  Mutual Fund Ownership

                  60.46%

                  Float

                  99.27%

                  5% / Insider Ownership

                  4.38%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Harris Assoc. Equity & Income Strategy

                  •  

                    4,065,250

                  • -13.88

                  • 4.15

                  • Oakmark Equity and Income Fund

                  •  

                    4,065,250

                  • 0.00

                  • 4.15

                  • Vanguard Selected Value Fund

                  •  

                    3,448,200

                  • 0.00

                  • 3.52

                  • JHancock Disciplined Value Mid Cap Fund

                  •  

                    2,267,075

                  • 1.65

                  • 2.32

                  • Janus Contrarian Fund

                  •  

                    1,749,258

                  • 0.00

                  • 1.79

                  • Vanguard Small Cap Index

                  •  

                    1,699,677

                  • -1.53

                  • 1.74

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,608,060

                  • 0.38

                  • 1.64

                  • JHancock Disciplined Value Fund

                  •  

                    1,550,565

                  • 4.98

                  • 1.58

                  • RidgeWorth Mid-Cap Value Equity Fund

                  •  

                    1,465,000

                  • 4.64

                  • 1.50

                  • iShares Core S&P Mid-Cap (AU)

                  •  

                    1,337,286

                  • 0.07

                  • 1.40

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Robeco Investment Management, Inc.

                  •  

                    7,284,778

                  • +11.10%

                  • 7.44

                  • Vanguard Group, Inc.

                  •  

                    6,719,909

                  • +0.79%

                  • 6.87

                  • Harris Associates L.P.

                  •  

                    5,471,790

                  • -11.85%

                  • 5.59

                  • Iridian Asset Management LLC

                  •  

                    5,153,368

                  • -2.22%

                  • 5.27

                  • Barrow, Hanley, Mewhinney & Strauss LLC.

                  •  

                    4,996,755

                  • +4.09%

                  • 5.11

                  • State Street Corp

                  •  

                    3,707,283

                  • -1.84%

                  • 3.79

                  • ARONSON+JOHNSON+ORTIZ

                  •  

                    3,640,480

                  • +56.45%

                  • 3.72

                  • Janus Capital Management LLC

                  •  

                    3,615,841

                  • -1.09%

                  • 3.69

                  • BlackRock Fund Advisors

                  •  

                    3,109,317

                  • -3.99%

                  • 3.18

                  • Dimensional Fund Advisors, Inc.

                  •  

                    2,578,994

                  • -0.48%

                  • 2.64

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Care

                  Type

                  Distressed

                  Style

                  Mid Core

                  Omnicare Inc was formed in 1981. It is a healthcare services company that provides complex pharmaceutical care. It operates in two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG). Through LTC, the Compan...morey provides pharmaceuticals and related pharmacy and ancillary services to long-term care facilities as well as chronic care facilities and other settings. SCG provides commercialization services for the biopharmaceutical industry in addition to end-of-life pharmaceutical care management for hospice care agencies. With respect to its clinical services, the Company provides pharmacy consulting, including monthly patient drug therapy evaluations, assist in compliance with state and federal regulations and provide proprietary clinical and health management programs. LTC also...more provides a suite of technology solutions based on its Omniview web-based platform that is intended to improve the efficiency of its customers' operations through such tools as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage, among others. LTC also provides a number of other products and services, including intravenous medications and nutrition products (infusion therapy products and services), respiratory therapy services, medical supplies and equipment (including billing the Medicare Part B program for eligible patients) and clinical care planning. The Company also provides pharmaceutical case management services for retirees, employees and dependents who have drug benefits under corporate-sponsored healthcare programs. SCG touches a broad spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its services are largely centered on the specialty pharmaceutical market. These services are based on five platforms: brand support services, third party logistics, patient assistance programs, specialty pharmacy and disease management for end-of-life care. Its brand support services, third party logistics and patient assistance programs are integrated, fee-for-service platforms which focus on helping the drug manufacturer to market, to distribute and obtain reimbursement for their products. In its specialty pharmacy platform, the Company provides dispensing of specialized pharmaceuticals that are high cost, have complex reimbursement and supply chain challenges, have limited patient populations and are not available through normal retail channels. These specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology and growth hormones. LTC's customers consist of skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers. The Company’s largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company’s pharmacies and the long-term care institutions it serves are subject to extensive federal, state and local regulation.lessless

                  Key People

                  Nitin Sahney

                  CEO/President/Director

                  James D. Shelton

                  Chairman of the Board/Director

                  Mr. Robert Kraft

                  CFO/Chief Accounting Officer/Senior VP

                  Barry P. Schochet

                  Director

                  Amy Wallman

                  Director

                  • Omnicare Inc

                  • 900 Omicare Center

                  • Cincinnati, OH 45202

                  • USA.Map

                  • Phone: +1 513 719-2600

                  • Fax: -

                  • omnicare.com

                  Incorporated

                  1981

                  Employees

                  13,900

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: